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Epiderm.al hyper-proliferation is a key feature of 
psoriasis, and a role for IGF-I in this process has 
previously been proposed. Herein we investigated the 
expression of IGF binding proteins in the psoriatic 
lesion and com.pared it with norm.al skin. With iu sit" 
hybridization, we found that IGFBP-3 mRNA was 
expressed in the basal layer of the epidermis in 
norm.al skin. IGFBP-3 was also detected imm.unohis-
tochemically, exclusively in the basal layer. In the 
psoriatic lesion, IGFBP-3 m.RNA was similarly lim.-
ited to the basal layer despite the characteristic ex-
pansion of the basaloid keratinocyte compartment 
and was detected only in the suprapapillary epider-
m.is, where IGFBP-3 m.RNA was more abundant than 
in norm.al or uninvolved epidermis, and IGFBP-3 
protein could be readily detected with specific anti-
I n sulit· l-like growth f.'lctor-I (IGF-I) is an important regulator of epidermal growth, as shown by the inhibition of the development of epidermal layers in the IGF-I receptor knockout mouse (Liu e/ ai, 1993). IGF-I was also shown to be the major cytokine responsible for the support of kera-
tinocyte ~owth by fibroblasts in culture (Barreca e/ ai, 1992). In 
psoriasis, stimulation ofkeratinocytes by IGF-I may be an important 
factor in the characteristic epidermal hyper-proliferation observed 
in the disease. Ristow (1993) showed that cu.itured psoriatic 
keratinocytes were more responsive to IGF-I stimulation than those 
from unaffected individuals, whereas inuTIunorustochemical inves-
tigations have shown that the IGF-I receptor is more widespread in 
tbe hyper-prolife rating epidermis of the psoriatic lesion (Hodak e( 
a/, 1996). The possibility of synergism between IGF-I and other 
cytokines active in the lesion is supported by the observation that 
IGF-I up-regulates the epidermal growth factor (EGF) receptor in 
psoriatic keratinocytes (Krane et ai, 1991). 
We have shown previously that keratinocytes synthesize insulin-
like growth factor binding protein-3 (IGFBP-3) and that IGFBP-3 
is the major epidermal IGF binding protein (Batch cf ai, 1994; 
Wraight et ai, 1994). In vitro, the synthesis of IGFBP-3 by kerati-
nocytes decreased their sensitivity to IGF-I stimulation (Wraight et 
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body. As with IGFBP-3 m.RNA, which represents the 
likely site of IGFBP-3 synthesis, IGFBP-3 was strictly 
limited to the basal keratinocytes of the suprapapil_ 
lary epidermis. By using an antibody to the cell cycle 
antigen Ki67, we also showed that the suprapapillary 
epiderm.is, where IGFBP-3 expression was maximal, 
contained few keratinocytes undergoing mitosis, 
whereas the tips of the rete pegs, where IGFBP-3 
expression was conspicuously absent, contained 
m.any keratinocytes undergoing mitosis. We suggest 
that IGFBP-3 is a growth inhibitor in basal keratino-
cytes and that absence of IGFBP-3 in the tips of rete 
pegs m.ay contribute to epidermal hyper-prolifera-
tion in the psoriatic lesion. Key lVords: it]'per-p,'olifer4-
tio1l./epideI'IIIis/lleratinoC]ltes. J Invest Del'IIlatol 108:452-
456, 1997 
ai, 1994), presumably by altel-ing IGF-I avai lability to the IG F-I 
receptor. In tills study we have investigated the expression of 
IGFDP-3 in psoriasis to determine whether potential changes in 
IGF-I availability occur in the psoriatic lesion . We used ill sitll 
hybridization and immunohistochemistry to detect IGFBP-3 
mRNA and protein in skin biopsies of psoriatic lesions. We also 
used an antibody to the cell cycle- specific prote in Ki67 to detect 
actively dividing cells in an effort to de termine how IGFBP-3 
expression corre lates with keratinocyte proliferation in the psoria tic 
les ion. 
MATER.lALS AND METHODS 
Skin Samples Punch biopsies nf psoriatic IcsiollS were taken under local 
anesthesia from various sites from adults of various ages (11 = 7) . Normal 
controls were obtained at autopsy from the skin over the chest of age- and 
sex-matched individuals with no known history of any dermatolngic 
condition (Victorian Institute of ForellSic Medicine, Melbourne, Australia). 
All use of human tissues in this study was approved by the relevant 
organizations (Victorian Institute of Forens.ic Medicine Ethics Committee 
and Royal Children 's Hospital Ethics in /-Iuman R esearch Committee, 
Melbourne, Australia). 
eDNA Probes and Antibodies The 457-bp partial eD NA for human 
IGFBP-3 (pHBP3-502) (Shimasaki and Ling, 1991) was kind ly provided by 
Dr. S. Shimasaki (Whittier Institute, La Jolla , CAl. An aftinity-purified 
biotinylated goat antibody specific for human IGFBP-3 (Bereket et ai , 1995) 
was provided by Dr. Christian Strasburger, Ludwig-Maximilians-Universi-
tat, Munich, German)' . An affinity-purified rabbit ant.i-Ki67 antibody was 
purchased from DAKO, Glostrup, Denmark. T his antibody recognizes the 
Ki67 antigen transiently expressed in proliferating cells during late G" S, M. 
and G, phases of the cell cycle. 
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Tissue Preparation Skin samplcs were fixed in 4% paraformaldehyde in 
phosphate-buffcred salule for at least 24 h at room temperature, then pro-
cessed through a graded ethanol selie" cleared in two changes of xylene, and 
infiltrated widl para.{fm wax. Skin sections (5 ILm) were cut, mounted on 
anill1oalkylsilanc-coated slides (Rentrop cl nl, 1986), mcubated overnight at 
37°C, and then analyzed by ill silll hybridization or inunwlohistochemistry. 
Preparation o f JSS-Labcled Comple m e ntary RNA (cRNA) I" Sit" 
Hybridization Probes Complementary (anti-sense) or noncomplemen-
tary (sense) cRNAs were prepared by first lincarizing the plasmid pHBP3-502 
widl Hilldill or Ei:oIU, respectively, as described (Edmondson cl nl, 1995). 
I" Sit" Hybridization Mounted sections were analyzed by ill s illl 
hybridization with an anti- sense 35S_labeled cRNA probe complementary 
ro human TGFBP-3 mRN A as described (Edmondson el nl, 1995). All skin 
samples were also ana lyzcd w ith a scnse (non complementary) " S-labe1ed 
IGFBP-3 cRNA probe as a control for nonspecific hybridization, with the 
res ult that apart from sparse evellly distributed silver grains, no hybridiza-
tion was de tectable in any section (data not shown). 
Immunohistochemistry Formalin-fixed paraffin-embedded tissue sec-
tions (5 /-Lln) were mounted on silanized glass microscope slides, dewaxed, 
and rehydrated as above. Sections were then immersed in 10 m.M sodium 
ci trate (PH 6.0) and boiled in a microwave oven for 10 min . Endogenous 
peroxidase activity was qucnched by incubatin g the sections in methanol 
containing 0.3% hydrogen peroxide. After incubation in 1% bovine serum 
albumul (molecular biology grade; Sigma, St. Lows, MO) and 20 J.Lg sheep 
IgG per m1 (Silenus Lahoratories, H awthorn, Australia) in phosphate-
buffered sa lme for 20 min, sections wcre incubatcd with thc same buffer plus 
eithcr biotinylated anti-h IGFI3P-3 (6 ILg per mI) or anti-K.i67 antibody 
(diluted 1:50 according to the manufilcturer's instructions) for 2 h or 30 
min, respectively, at room temperature in a humidified container. Specifi-
cally bOW1d primary antibody was detected using dle Vectastain ABC Elite 
kit, using peroxidase-conjugated anti-rabbit second stage antibody and 
3,3'-diaminobenzidiuc (b rown, Vector Laboratories, Burlingam e, CA) or 
3-amino-9-ethylcarbazole (red, Sigma, St. Louis , MO) as the chromogenic 
peroxidase substrates . The red 3-amino-9-ethylcarbazole substrate was used 
in the nonpsoriatic skin samples because of the need for enhanced contrast 
due to the weak signal usually obtain ed in normal SkUl . For the biotinyhlted 
anti-TGFBP-3, the second-stage antibody incubation step was omitted. 
Inununohistochemical specificity was demonstrated by co-incubatUlg skin 
sections widl dle anti- IGFBP-3 antibody and 15 J.Lg recombinant human 
IGFBP-3 pcr ml (generously provided by Dr Leon Bach , Austin Hospital , 
Melbourne, Australia) as competitor. After immW1ostailill1g, sections were 
lightly counterstained w ith hematm..}'lin. 
RESULTS 
I GFBP-3 mRNA Expression in Normal Epidermis Is Limited 
t o the Basal Layer The analysis of skin from age- and sex-
matched controls (n = 7) b y using a 35S-labeled cRNA probe 
complementary to the human IGFBP-3 mRNA showe d that 
IGFBP-3 mRNA is located exclu sively in the b asal layer of the 
epidermis (Fig 1). M ost basal k e ratinocytes app eared to express 
IGFBP- 3 mRNA; however, occasionally IGFBP-3-negative cells 
were detected adjacent to IGFBP-3-positive cells (Fig 1a) . Basal 
keratinocytes of the re te pegs did not eA-press IGFBP-3 mRNA (Fig 
1a), and tlus w as consiste ntly ob served in all skin samples an alyzed . 
Figure 1b shows skin £i:om a 72-y-o ld m ale and is an age- and 
sex-matched normal control for the p soriasis biopsy shown in Figs 
3 and 4. The d arkfie ld exposure (Fig 1e) more clearly shows tile 
location of the IGFBP-3 mRNA in the b asal epiderm al layer. The 
results show n in these and all figures are representative of results 
o btained with aU seven biopsies and match e d controls. 
IGFBP-3 Protein Expression in Normal Epidermis Is Lim-
ited to the Basal Layer IGFBP-3 was detected in the basal layer 
of normal epide nnis, as is indicated by th e re d staining (Fig 2a) . No 
staining was de tecte d in suprabasa l keratinocytes and, as wjth 
IGFBP-3 mRNA, stretches of IGFBP- 3-negative basal keratino-
cytes were visible. A negative control (no primary an tibody) for the 
IGFBP-3 antibody is shown in Fig 21). 
IGFBP-3 mRNA Expression in the Psoriatic Lesion Is Lim-
ited to the Supra papillary Epidermis All the biopsies of 
psoriatic skin exlubite d acan thosis, e lo ngated re te ridges , 3l1d an 
expanded basaloid k e ratinocyte compartment in th e epidermis. 
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Fignre 1. IGFBP-3 mRNA expression in normal epidermis is lim -
ited to the basal layer. Sections (5 J.Lm) of11ormal skin were ana lyzed by 
ill s il1l hybridization with it J5S-labeled human cRNA complementary to 
IGFBP-3 mRNA as described ill Mnterinls nIId Methods. After e""posing the 
slides to photographic emulsion, specific hybridization to ceUular mRNA is 
visible as black silvcl' grains under light- field photography or white grains 
under dark-field photography. (n) N ormal chest skin £i'om a 49-y-old female 
showing hybridization to TGFBP-3 mRNA exclusively in the single basal 
keratinocyte layer of the epidermis. Basa.! keratinocytes of rete pegs were 
lacking in IGFBP-3 mRNA. Light-fic.1d image. Scnle bnr, 50 J.Lm. (I!) N ormal 
chest skin from a 72-y-old male showing reduced IGFBP-3 ruRNA ill the 
epidermis. T he brown stainillg in the epidermis is mclanin. Light-field 
image. Scnle bnr, 100 J.Lm. (c) Samc section as Pnllel b, viewed under 
dark-field optics, showing the basal localization of th e IGFBP-3 mRNA. 
Senle bnr, 100 J.Lm. 
Analysis of psoriatic biopsies with th e 35S-labele d cRNA ill situ 
hy bridization probe complementary to the human IGFBP-3 mRNA 
d e m o nstra te d that IGFBP-3 n1.RNA was again clearly associate d 
with tl1e basal k e ratinocyte layer and, despite th e expande d b asaloid 
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Figure 2. IGFBP-3 protein expression in normal epidermis is lim-
ited to the basal layer. Sections (5 /-Lm) of normal skin (chest, 48-y-old 
female) were analyzed with a biotinylated antibody specific for human 
IGFBP-3 as described ill Materials aIId Methods. (a) Red IGFBP-3 inununo-
staining can be observed in the basal layer. Scale bar. 50 /-LLn. (b) A negative 
control (no primary antibody) for the IGFBP-3 antibody shows no red 
staining in the basal layer. Scale bal'. 250 /-Lm. 
keratinocyte compartment, IGFBP-3 mRNA was never detected in 
cells of even the immediate suprabasallayer (Fig 3a). This expres-
sion was confined, however, to the basal layer of the suprapapillary 
epidermis (Fig 3a,b) and was never in the deep interpapillary 
epidermis of the rete pegs. The intensity ofIGFBP-3 hybridization 
in psoriatic suprapapillary epidermis was consistently higher than in 
the epidermis of any normal skin samples (Fig 3b). Figure 3c, a 
transverse section through the upper region of a dermal papilla, 
shows IGFBP-3 mRNA hybridization apparently associated with 
individual cells of the suprapapillary basal epidermis. 
IGFBP-3 Protein Expression in the Psoriatic Lesion Is Lim-
ited to the Basal Keratinocytes of the Suprapapillary Epider-
mis IGFBP-3 protein was clearly detected in the epidermis of the 
psoriatic lesion and. as witll IGFBP-3 mRNA, the localization of the 
IGFBP-3 protein was strictly limited to tIle suprapapillary epidernus 
(Fig 4a). IGFBP-3 expression was limited to the basal layer and was 
apparently absent in the inlmediate suprabasal layer (Fig 4b). 
To determine whether the staining of the basal keratinocytes in 
both normal and psoriatic skin represented specific recognition of 
IGFBP-3 by the biotinylated anti-IGPBP-3 antibody, the antibody 
incubations w ere repeated in the presence of 15 [.Lg recombinant 
human IGFBP-3 per mI. Recombinant IGFBP-3 prevented the 
appearance of staining in the basal layer, showing that the staining 
patterns were due specifically to the presence ofIGFBP-3 (Fig 4c). 
The Tips of Rete Pegs Are Zones of High Epidermal 
Proliferation in Psoriasis Immunolustochemical staining with 
the antibody to the cell cycle-specific protein Ki67 showed that the 
majority of actively proliferating keratinocytes were in the tips of 
the rete pegs (Fig Sa). Although Ki67-positive cells were visible in 
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the basal layer, most were present in the immediate suprabasal 
layers. Few positive cells were found in the suprapapillary epider-
mis. A negative control (pre-immune rabbit serum) for the Ki67 
antibody is shown in Fig 5b. 
DISCUSSION 
IGF-I is a potent mitogen of epidermal keratinocytes ill vitl'o 
(Ristow and Messmer, 1988; Neely et ai, 1991; Barreca et al. 1992) 
and is essential for the normal growth of the epidermis (Liu et ai, 
1993). Potential sources of IGF-I available to the epidernus are 
dermal fibroblasts (Barreca et aI, 1992; Tavakkol et al. 1992), 
epidennal melanocytes (Tavakkol et ai, 1992). dermal macrophages 
(Arkins et al. 1995), or the circulation via the dermal capillaries. The 
likely epidernlal targets for IGF-I in normal skin are tlle basal 
keratinocytes. because the IGP-I receptor is concentrated in this 
layer (Krane et al. 1991; Hodak et al. 1996) . In psoriasis, IGF-I 
receptor expression persists into supra basal layers (Krane et ai, 1992; 
Hodak et al. 1996). allowing for potential IGF-J stimulation and 
possibly contributing to the existence of Ki67-positive keratino-
cytes suprabasally. A direct causal relationship has not been estab-
lished, although it is interesting to note that ill IJitro, keratinocytes 
isolated from psoriatic patients. even from uninvolved skin. were 
found to be more susceptible to IGF-I stimulation than keratino-
cytes from unaffected individuals (Ristow, 1993). 
The localization ofIGFBP-3 mRNA shown in tlus study by ill sit" 
hybridization demonstrates the likely site of synthesis of IGFBP-3. 
It was conceivable , however. that the localization ofIGFBP-3 itself 
could be more widespread if. for example, basal cells continued 
secreting IGFBP-3 after exiting the basal layer, even if IGFBP-3 
mRNA steady-state levels had become undetectable. By using an 
IGFBP-3-speciflc antibody, we found that IGFBP-3. like its 
mRNA, was present exclusively in basal keratinocytes of normal 
and psoriatic skin and was limited to the suprapapillary epidernus in 
psoriatic skin. 
The distribution of actively proliferating cells that we observed is 
consistent with previous studies using anti-Ki67 (Hodak et al. 1996) 
and other markers of cell proliferation (Van Erp et ai, 1989; 
Weinstein and McCullough. 1990; Gillitzer et al. 1993). The 
suprabasal Ki67-positive keratinocytes are likely to correspond to 
the proposed "transit amplifying" compartment (Potten. 1974; 
Laporte and Heenen, 1994). IGFBP-3 expression therefore appears 
to underlie zones of lowest keratlllOcyte proliferatiou rates within 
the lesion and is absent in the basal layer underlying zones 
exhibiting lugh proliferation rates. 
Clearly, the apparent pathophysiologic regulation of IGFBP-3 
expression that we have observed herein is occurring in regions of 
the epidermis that possess the potential to respond proliferatively to 
IGF-I. We previously demonstrated that IGFBP-3 production by a 
keratinocyte cell line inhibited its response to IGF-I (Wraight et ai , 
1994). The fact that IGFBP-3 and the IGF-I receptor co-localize in 
nonnal epidermis suggests that IGFBP-3 provides an essential control 
step in keratinocyte proliferation by !inuting tile exposure of basal 
keratinocytes to IGF-l. In the psoriatic lesion, tIle loss of IGFBP-3 
from tlle lower epidemlal basal layer may result in uncontrolled 
exposure to IGF-I. in turn leading to tlle characteristic lugh frequency 
of hyper-proliferating keratinocytes observed in tllis precise location. 
The apparent loss of IGFBP-3 expression from the basal layer of 
the rete tips in psoriasis may represent an expansion of sinUlar 
IGFBP-3-negative cells that we consistently observed in the rete 
pegs of normal s.kin. Alternatively, there may be regulatory forces 
inhibiting IGFBP-3 gene expression in tlle rete tips of the psoriatic 
lesion. It is generally agreed tllat psoriasis is primarily a disorder of 
inunune function at tIle dermal-epidermaljunction (Bata-Csorgo el 
al. 1995). The increased activity of inflammatory cells close to tlle 
epidernus and tlle resulting local release of inflammatory mediators 
is one likely explanation for the apparent polarization of IGFBP-3 
expression that we have observed . Many cytokines are known to be 
overexpressed in psoriatic skin: granulocyte-macrophage colony-
stimulating factor (Takematsu and Tagami, 1990), interferon-'Y 
(Bjerke et ai, 1983; Barker et al. 1991; Uyemura et al. 1993; Schnud 
et ai, 1994), interleukin-1{3 (Schmid eI ai, 1993). interleukin-6 
VOL. 108, NO. APIUL 1997 
F igure 3. IGFBP-3 mRNA expression in the psoriatic lesion is 
lin:Lited to the basal layer of the suprapapillary epidermis. Sections 
(5 J..lm) of lesional skin were an alyzed by in sil.1I hybridization with a 
35S-1abeled hUlllan cRNA complementary to IGFBP-3 mRNA as described 
in Materials alld Met/rods. (a) Psoriatic lesion from the an terior thigh of a 
79- y -old male, showing hybridization to IGFBP-3 mRN A exclusively in the 
suprapapillary epidermis. Light-field image. Scale bar, 50 /Lm . Kcratinocytes 
at the tips of the rete pegs arc devoid of IGFBP-3 mRNA hybridization. 
IGFEP-3 mRNA, where expressed, is limited to the single basal keratino-
cyte layer as in normal skin (Fig 1). (b) Same section as PIlllel a, viewed 
under dark-field optics, showing the increased abundance of IGFBP-3 
mRNA in the supnlpapilJary region compared with the epidermis of the 
age- and sex-matched normal skin control shown in Fig H ,c. Scale bar, lOa 
/Lm . (c) Transverse section through the upper region of a dermal papilla 
showing IGFBP-3 mRNA hybridization over indi vidual basal keratinocytes 
of the suprapapillary epidermis. Light-fi eld image. Scale bar, 30 f.Lm . 
(Grossman el nl, 1989), interleukin-8 (Gillitzer et n/, 1991; Nickoloff 
et ai, 1991; Schmid c ( nl, 1993), and transforming growth factor-a 
(Elder ef n/, 1989; Schmid eI nl, 1993). At least one of these, 
transfonning growth £1ctor- a, has the potential to influence IG-
FBP- 3 expression. We have dem onstrated that activation of the 
receptor for transfonnin g growth fac to r-a on keratinocytes, the 
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Figure 5. Actively proliferating keratinocytes are mainly located 
in the tips of rete pegs. An antibody to the cell cycle-specific antigen 
Ki67 was used to identify actively proliferating cells in the lesion (anterior 
thigh, 79-y-old male). (a) Some Ki67-positive cells are visible in the basal 
layer but occur most frequently in the tl1Tee or four supra basal layers of 
keratinocyces in tlle tips of tll e rete pegs. Few cells of the suprapapillary 
epidermis are undergoing mitosis. Scale bar, 50 f.Lm. (b) A negative control 
(pre-immune rabbit serum) for the Ki67 antibody shows no staining. Scale 
bar, 100 }.L111. 
EGF receptor, profoundly inhibits the expression ofIGFBP-3 in the 
HaCaT keratinocyte cell line (Wraight and Werther, 1995) and in 
early-passage cultured keratinocytes (unpublished results). In addi-
tion to transforming growth factor- a, the epidermal growth factor 
receptor is overexpressed in the lesion (Krueger et ai , 1990; 
Higashiyama cf nl, 1994). T here is evidence for synergistic stimu-
lation of keratinocyte growth via IGF-l upregulation of the EGF 
receptor (Krane ef ai , 1991) . Although as yet there is no ill IJivo 
evidence that the apparent inhibition of IGFBP-3 expression in the 
tips of the rete pegs occurs via the EGF receptor, it is possible that 
this i.nhibition represents an additional forl11 of synergy between 
IGF-I and another or several local cytokines to cause epideml al 
hyper-proliferation . 
It is perhaps surprising that despite the gross expansion of the 
basaloid or germinative epidemlal compartment in psoriasis, IG-
Figure 4. IGFEP-3 protein expression in the psoriatic lesion is limited to the basal layer of the suprapapillary epidertnis. Sections (5 /Lm) of 
lesional skin (anterior th.igh, 79-y-old male) were analyzed with a biotinyla ted antibody specific for human IGFBP-3 as described in Materinls alld Methods. 
(a) IGFBP-3 immunostaining can be observed in the suprapapilJary epidermis but not in tll e tips of the rete pegs. Scale bar, 250 }.Lm. (b) IGFBP-3 
irnmunostaining is limited to the basal keratinocyte layer and absent from the immediate suprabasallayers. Senle bar, 50 f.Lm. (c) lmmunosraining is blocked 
by the inclusion of 15 /Lg recombinant human IGFBP-3 per ml with the antibody incubation showing that tlle staining patterns were due specifically to the 
presence of IGFBP-3 . Senle bar, 250 }.Lm. 
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FBP-3 expression is still strictly confined to the single basal keratino-
cyte layer as it is in nOl1nal skin . T lus suggests that IGFBP-3 is one of 
d lC most specific markers of the basal keratinocyte population yet 
discovered, because existing markers of basal keratinocytes, keratins 5 
and 14 (Bernerd el aI, 1992) or the {31 integl'in subunit (Hertle cl aI, 
1992), fail to maintain a basa l localization in hyper-proliferative 
epidemlis. An intriguing explanation for the tight associa tion of 
IGFBP-3 with the basal keratinocyte layer might be that IGFBP-3 is an 
early growth arrest protein, expressed during the cel.l cycle near the 
point at wluch the decision to differentiate is taken by a progelutor cell. 
T his is consistent with our observations in nomla.! skin that an 
IGFBP-3-positive keratinocyte can be situated nex t to all IGFBP-3-
negative keratinocyte in tile basal layer, suggesting tllat something 
other than a spatia l signal (e.g., proximity to tile basa l lanuna) is 
con trol.ling IGFBP-3 gene expression. T he IGFBP-3 gene promoter 
contains a response element for the growth arrest gene product p53 
shown to be active ill I/itro (Buckbi.l1der el aI, 1995) , so IGFBP-3 is 
certain.lya candidate member of tile filmily of early grOWtll arrest gene 
products. Although our study provides circumstalltial evidence for a 
role for JGFBP-3 in growth arrest, others have also proposed that 
keratinocyte IGFBPs (Kato el aI, 1995) and IGFBP-3 in particular (011. 
el aI, 1995) are growth inlubitors and even that IGFBP-3 is growth 
inlubi tory in tile absence of any IGF-I effects (Va lentinis cl aI, 1995 ). 
Our study shows that IGFBP-3 expression within the psoriatic 
lesion is spatially regu lated in a way that is consistent with a ro le as 
a basa l kerati.l1ocyte growth inlubitor. T he local factors giving ri se 
to disti nctive IGFBP-3 expressio n patte rn rem ain to be determined , 
and its causa l role in the chara cteristic pattern of keratinocyte 
proliferation in psoriasis has ye t to be elucidated . The aberrant 
cytokine profil e of psOl'ia tic ski n is li kely to be a major influence o n 
epide rmal lGFBP-3 expression . Further studies on the control of 
norma l and hyp er-pla stic epidermal growth wi ll better explain the 
interpl ay between IGF-I and the cytokine network via IGFBPs. 
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